How Chemotherapy Works: Cancer Treatment Explained

What Is Chemotherapy?

Chemotherapy is the use of chemical agents (drugs) to treat cancer by killing cancer cells, stopping them from dividing, or slowing their growth. It is a systemic treatment — unlike surgery or radiation (which target specific locations), chemotherapy travels through the bloodstream to reach cancer cells throughout the body, making it particularly valuable for cancers that have spread (metastasized) or that cannot be precisely targeted.

Chemotherapy has been used in cancer treatment since the 1940s and remains one of the most widely used cancer treatments today, though it has increasingly been supplemented by targeted therapy, immunotherapy, and other more precise approaches.

How Chemotherapy Kills Cancer Cells

Cancer is characterized by cells that divide uncontrollably. Most chemotherapy drugs exploit this: they target rapidly dividing cells and disrupt the mechanisms cells use to replicate. Different drug classes work through different mechanisms:

• Alkylating agents (cyclophosphamide, cisplatin): Damage DNA directly, preventing cells from replicating their genetic material. Among the oldest and most commonly used chemotherapy drugs.
• Antimetabolites (methotrexate, 5-fluorouracil): Mimic natural building blocks of DNA and RNA, disrupting the synthesis of genetic material needed for cell division.
• Anthracyclines (doxorubicin, daunorubicin): Intercalate into DNA and inhibit topoisomerase, an enzyme essential for DNA replication.
• Taxanes (paclitaxel, docetaxel): Stabilize microtubules — structural components cells need to separate chromosomes during division — preventing cell division from completing.
• Vinca alkaloids (vincristine, vinblastine): Interfere with microtubule formation, halting the mitotic spindle needed for cell division.

Why Chemotherapy Causes Side Effects

The critical limitation of traditional chemotherapy is its lack of selectivity. Chemotherapy drugs attack all rapidly dividing cells — not just cancer cells. The body has several populations of rapidly dividing healthy cells that are also affected:

• Bone marrow: Produces blood cells — damage causes anemia (low red blood cells), increased infection risk (low white blood cells), and bruising/bleeding (low platelets)
• Hair follicles: Rapid cell division needed for hair growth — causing the hair loss (alopecia) associated with many chemotherapy regimens
• Gastrointestinal lining: Rapid renewal needed to maintain gut integrity — causing nausea, vomiting, diarrhea, and mouth sores (mucositis)
• Reproductive cells: Can cause temporary or permanent infertility

Importantly, healthy cells generally have better DNA repair mechanisms than cancer cells, which is why they recover after treatment while cancer cells are more likely to die. This difference, though not absolute, underlies the therapeutic window of chemotherapy.

Treatment Administration

Chemotherapy is given in cycles — periods of treatment followed by rest periods that allow the body's healthy cells to recover. A typical cycle might be 3–4 weeks, with treatment given for the first few days followed by weeks of recovery. A full course of chemotherapy typically involves 4–8 cycles over 3–6 months.

Chemotherapy can be administered:

• Intravenously (IV): Most common; delivered through a peripheral IV, central venous catheter, or implanted port
• Orally: Pills or capsules taken at home (capecitabine, temozolomide)
• Intrathecally: Injected into the spinal fluid to treat brain or spinal cancer
• Topically: Creams for certain skin cancers

Combination Chemotherapy

Most chemotherapy regimens use multiple drugs simultaneously. The rationale: different drugs attack cells through different mechanisms, reducing the chance that cancer cells develop resistance, and allowing lower doses of each drug (reducing individual drug toxicity while maintaining effectiveness). Regimens have names like CHOP (lymphoma), FOLFOX (colorectal cancer), or AC-T (breast cancer).

Modern Advances: Precision Oncology

Traditional chemotherapy's broad mechanism is increasingly being supplemented or replaced by more targeted approaches:

• Targeted therapy: Drugs that block specific molecular targets driving cancer growth (imatinib for chronic myeloid leukemia — a landmark example)
• Immunotherapy: Checkpoint inhibitors (pembrolizumab, nivolumab) that unleash the immune system against cancer
• Antibody-drug conjugates (ADCs): Chemotherapy drugs attached to antibodies that guide them specifically to cancer cells, reducing damage to healthy tissue

These advances have transformed treatment for many cancers. For some cancer types, targeted therapy has made chemotherapy largely unnecessary. But traditional chemotherapy remains a cornerstone of treatment for many cancers and is often combined with newer approaches.